ReviewProbiotics and antimicrobial proteins2026
Cysteine-Rich Peptides in Food Systems: Structure, Sources, Functional Properties, Potential Applications, and Future Perspectives.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cysteine-rich peptides (CRPs) are structurally diverse bioactive peptides in which cysteine residues form disulfide bonds or, in some lanthipeptides, cysteine-derived thioether bridges. These constraints can improve resistance to thermal, chemical, and enzymatic stress, although stability and activity remain peptide- and matrix-dependent. CRPs have attracted interest as antimicrobial, antioxidant, and immunomodulatory agents in food preservation, functional foods, and active packaging. Nisin provides the clearest regulatory and commercial precedent: this lanthipeptide is used in selected food categories to control susceptible Gram-positive pathogens and spoilage organisms. Evidence for most plant defensins, cyclotides, and engineered CRPs, however, remains based on in vitro, preclinical, or food-model studies. This review examines CRP structures, sources, functional properties, potential food applications, and regulatory considerations. It also evaluates quantitative efficacy data, manufacturing and delivery constraints, allergenicity and toxicity, possible resistance, and the need for matrix-specific validation. CRPs should therefore be considered candidate components of validated preservation and delivery strategies rather than universal replacements for conventional additives.
Indexed as
Identifiers
42873457What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.